Add to ORKGepression is estimated to affect nearly 340 million people worldwide and 18 million people in th
Purpose Duloxetine (Cymbalta®) is a serotonin (5-HT) and norepinephrine (NE) re-uptake inhibitor ind...
Introduction: Affective disorders, including major depressive disorder (MDD), are among the most sev...
Management of depression presents a significant medical challenge. Drugs with improved efficacy and ...
Duloxetine is a serotonin-noradrenaline reuptake inhibitor with established efficacy for the short-t...
BACKGROUND: Major depressive disorders (MDD) present a significant public health problem, in terms o...
peer reviewedDuloxetine (Cymbalta is an antidepressant of the class of serotonin noradrenaline reupt...
To review efficacy of duloxetine for physical symptoms and depressive illness in patients with at le...
The elderly population is more frequently subjected to depressive mood compared to the general popul...
BACKGROUND: Although pharmacological and psychological interventions are both effective for major de...
To assess and compare the levels of functioning in patients with major depressive disorder treated w...
Although pharmacological and psychological interventions are both effective for major depression, an...
OBJECTIVE: Experience of pain in major depressive disorder (MDD) can complicate diagnosis and impair...
Objective: Major depressive disorder (MDD) is a significant public health concern and challenges hea...
A developing concept is that antidepressant strategies which combine multiple mechanisms of action m...
The aim of the present paper was to compare the efficacy and safety of duloxetine with paroxetine in...
Purpose Duloxetine (Cymbalta®) is a serotonin (5-HT) and norepinephrine (NE) re-uptake inhibitor ind...
Introduction: Affective disorders, including major depressive disorder (MDD), are among the most sev...
Management of depression presents a significant medical challenge. Drugs with improved efficacy and ...
Duloxetine is a serotonin-noradrenaline reuptake inhibitor with established efficacy for the short-t...
BACKGROUND: Major depressive disorders (MDD) present a significant public health problem, in terms o...
peer reviewedDuloxetine (Cymbalta is an antidepressant of the class of serotonin noradrenaline reupt...
To review efficacy of duloxetine for physical symptoms and depressive illness in patients with at le...
The elderly population is more frequently subjected to depressive mood compared to the general popul...
BACKGROUND: Although pharmacological and psychological interventions are both effective for major de...
To assess and compare the levels of functioning in patients with major depressive disorder treated w...
Although pharmacological and psychological interventions are both effective for major depression, an...
OBJECTIVE: Experience of pain in major depressive disorder (MDD) can complicate diagnosis and impair...
Objective: Major depressive disorder (MDD) is a significant public health concern and challenges hea...
A developing concept is that antidepressant strategies which combine multiple mechanisms of action m...
The aim of the present paper was to compare the efficacy and safety of duloxetine with paroxetine in...
Purpose Duloxetine (Cymbalta®) is a serotonin (5-HT) and norepinephrine (NE) re-uptake inhibitor ind...
Introduction: Affective disorders, including major depressive disorder (MDD), are among the most sev...
Management of depression presents a significant medical challenge. Drugs with improved efficacy and ...